Home
>
US Stocks
>
KemPharm Inc
KemPharm Inc
KMPH

KemPharm Inc

$9.688.89%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
9.28
Today Low/High
9.28 / 9.85
52 Week Low/High
$5.08 / $18.15
Market Cap
$327.63M

Company Details

KemPharm is a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs to treat serious medical conditions through its proprietary LAT™ (Ligand Activated Therapy) technology. KemPharm utilizes its proprietary LAT™ technology to generate improved prodrug versions of FDA-approved drugs as well as to generate prodrug versions of existing compounds that may have applications for new disease indications. KemPharm's prodrug product candidate pipeline is focused on the high need areas of attention deficit hyperactivity disorder, or ADHD, and stimulant use disorder. KemPharm's co-lead clinical development candidates for the treatment of ADHD, KP415 and KP484, are both based on a prodrug of d-methylphenidate, but have differing duration/effect profiles. In addition, KemPharm has received FDA approval for APADAZ®, an immediate-release combination product containing benzhydrocodone, a prodrug of hydrocodone, and acetaminophen.
Organisation
KemPharm Inc
Headquaters
Celebration, Florida, US
Employees
22
Industry
Health Technology
CEO
Travis Mickle

Discover more

Frequently Asked Questions

What is KemPharm Inc share price today

Can Indians buy KemPharm Inc shares?

How can I buy KemPharm Inc shares from India?

Can Fractional shares of KemPharm Inc be purchased?

What are the documents required to start investing in KemPharm Inc stocks?

We are a SEBI registered investement advisor